Aehr Test Systems (AEHR) Director Laura Oliphant Sells 57 Shares

Director Laura Oliphant sold 57 shares of Aehr Test Systems, Inc. (NasdaqCM: AEHR) on June 18, 2026. This transaction was not part of a planned trading program. Shares of Aehr Test Systems traded at $112.81 on Monday.

What Changed in Laura Oliphant's Aehr Test Systems Position

Laura Oliphant, who serves as a director at Aehr Test Systems, reduced her holdings by selling 57 shares. This transaction was recorded on June 18, 2026, and was not pre-scheduled under a trading plan.

Other Institutional Activity in Aehr Test Systems

Among other institutional investors, BlackRock, Inc. grew its holdings by 159,794 shares, bringing its total to 2,286,899 shares valued at approximately $84.8 million, marking a 7.5% increase. FMR LLC reduced its position by 365,281 shares, leaving it with 2,142,639 shares worth about $79.4 million, a 14.6% decrease. AWM Investment Company, Inc. added 57,200 shares, now holding 1,593,971 shares valued at $59.1 million, reflecting a 3.7% increase. Price T Rowe Associates Inc /MD/ significantly increased its stake by 1,314,967 shares, reaching a total of 1,349,351 shares worth $50 million, a staggering 3824.4% increase. Vanguard Capital Management LLC opened a new position with 1,281,857 shares, valued at $47.5 million.

Aehr Test Systems, Inc. Stock Up 42.3%

On Monday, shares of Aehr Test Systems traded at $112.81. The company boasts a market capitalization of approximately $3.63 billion. It has a forward P/E ratio of 768.7, with a beta of 3.183, indicating high volatility. The stock's 52-week range is between $10.89 and $126.62, with a 50-day moving average of $94.47 and a 200-day moving average of $45.23. Aehr Test Systems maintains a strong financial position, with a current ratio of 10.97 and a quick ratio of 5.79, though it has a debt-to-equity ratio of 7.223.

Recent Earnings

Aehr Test Systems reported revenue of $45.3 million, though it experienced a revenue decline of 43.7%. The company posted a net margin of -25.2% and a return on equity of -8.7%. Its next earnings report is expected on July 14, 2026.

Insider Buying and Selling at Aehr Test Systems, Inc.

In addition to Laura Oliphant's sale, several other insiders have sold shares recently. Executive VP of R&D Didier Wimmers sold 332 shares on June 3, 2026, at an average price of $114.59. CFO Chris Siu sold 350 shares at $93.62 on June 1, 2026, and another 2,070 shares at $107.06 on May 14, 2026. Howard Slayen sold 6,819 shares at $104.73 on May 13, 2026. Geoffrey Gates Scott sold 10,000 shares on April 29, 2026.

Analysts Set New Price Targets

Craig-Hallum maintained a hold rating with a $21.00 price target on January 9, 2026. Lake Street initiated coverage with a buy rating and a $29.00 target on December 17, 2025. The overall analyst consensus for Aehr Test Systems is a strong buy, with a mean target price of $63.67 based on three analyst opinions.

About Aehr Test Systems

Aehr Test Systems, Inc. is a technology company based in Fremont, California. It specializes in providing test solutions for semiconductor devices, including systems for testing, burn-in, and stabilization. The company's products are used in various applications, such as mobile phones, tablets, and computing devices. Aehr Test Systems operates in the United States, Asia, and Europe, employing approximately 136 people under the leadership of CEO Gayn Erickson.

Bottom Line

Laura Oliphant's recent sale of Aehr Test Systems shares is part of a broader pattern of insider activity at the company. Investors often keep an eye on such transactions for insights into company sentiment. Aehr Test Systems continues to navigate a challenging market with its high P/E ratio and volatile stock performance. As always, it's important to remember that insider sales can occur for many reasons unrelated to the company's prospects.